The Denmark-based healthcare leader has several attractive pipeline candidates that should help it maintain a strong position in this space over the next few years
Psoriasis is widely viewed as an immune-mediated inflammatory disease that is associated with the expansion and activation of T helper (Th)1, Th17 and Th22 cells, and the increased expression and levels of cytokines detectable locally in skin lesions and, frequently, systemically in the circulation [1]
Hydroxocobalamin injection package insert. Parsippany, NJ, Actavis Pharma, Inc
L-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial
October 4, 2024: Sharp Rise in Lawsuits Against Eli Lilly and Other GLP-1 Manufacturers September 24, 2024: Alabama Woman Files Mounjaro Lawsuit Against Eli Lilly for Severe Gastrointestinal Injuries September 10, 2024: Mounjaro Drugmaker to Sell Tirzepatide D2C Through Its Online Pharmacy Eli Lilly, the manufacturer of Mounjaro, recently announced plans to begin selling low doses of tirzepatide, the active ingredient in Mounjaro and Zepbound, directly to consumers
